摘要：

The present invention comprises at least one acid-labile proton pump inhibitor and at least one antacid, improved bioavailability, chemical stability, physical stability, dissolution profile, disintegration time , safety, and improved histological other pharmacokinetic, pharmacodynamic, relates to a pharmaceutical formulation having a chemical and / or physical properties. The method for the present invention, gastrointestinal disorder or disease in a subject in need thereof or associated with the disorder or disease of the gastrointestinal, or the symptoms associated therewith, to reduce the risk of developing treatment, prevention or it, kits, combinations, and directed to the composition.

展开